Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of NuPathe, Inc. (“NuPathe” or the “Company”) (Nasdaq:PATH) relating to the proposed acquisition of the company by Endo Health Solutions.
Click here to learn more about the investigation
, or call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, NuPathe shareholders will receive only $2.85 in cash for each share of NuPathe stock they own. In addition, NuPathe shareholders will have the right to receive additional payments of up to $3.15 per share contingent upon ZECUITY reaching specified net sales. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of NuPathe for not acting in the Company’s shareholders' best interests in connection with the sale process.
The transaction may undervalue the Company and may result in a loss for many long term NuPathe shareholders. NuPathe stock traded above the sale price at $4.81 per share on March 15, 2012 and traded at $3.65 per share as recently as April 10, 2013. In addition, an analyst has set an $8.00 per share price target on NuPathe shares.
If you own shares of NuPathe common stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at
, by visiting
, or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and case action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.